tirzepatide easo guideline

EASO Update Gives Clearer Roles for Tirzepatide, Semaglutide — Photo by Wolfgang Weiser on Pexels

Semaglutide The Hidden Advantage Over Tirzepatide?

In a 26-week Danish trial, semaglutide cut heavy drinking days by 30%, showing a hidden advantage over tirzepatide for patients struggling with both obesity and alcohol use disorder. This benefit complements its robust weight-loss profile, making it a compelling first-line option when the new EASO update rolls out. Medical Disclaimer: